Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Locations


Orders Processing,
Shipping & Receiving,
Warehouse

2 Shaker Rd Suites
B001/B101
Shirley, MA 01464


Production Lab

Floor 6, Suite 620
20700 44th Avenue W
Lynnwood, WA 98036

Telephone Numbers



Tel: +1 (206) 374-1102
Fax: +1 (206) 577-4565

Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-C167337-400 400 µl $393 
DDX49 Antibody - DDX49 Antibody immunohistochemistry of formalin-fixed and paraffin-embedded human breast carcinoma followed by peroxidase-conjugated secondary antibody and DAB staining.
DDX49 Antibody - Western blot of DDX49 Antibody in HeLa cell line lysates (35 ug/lane). DDX49 (arrow) was detected using the purified antibody.
DDX49 Antibody - DDX49 Antibody flow cytometry of HeLa cells (right histogram) compared to a negative control cell (left histogram). FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.
DDX49 Antibody - DDX49 Antibody immunohistochemistry of formalin-fixed and paraffin-embedded human breast carcinoma followed by peroxidase-conjugated secondary antibody and DAB staining.
DDX49 Antibody - Western blot of DDX49 Antibody in HeLa cell line lysates (35 ug/lane). DDX49 (arrow) was detected using the purified antibody.
DDX49 Antibody - DDX49 Antibody flow cytometry of HeLa cells (right histogram) compared to a negative control cell (left histogram). FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.
1 of 3
2 of 3
3 of 3

Polyclonal Rabbit anti‑Human DDX49 Antibody (aa385‑413, IHC, WB) LS‑C167337

Polyclonal Rabbit anti‑Human DDX49 Antibody (aa385‑413, IHC, WB) LS‑C167337

Antibody:
DDX49 Rabbit anti-Human Polyclonal (aa385-413) Antibody
Application:
IHC, IHC-P, WB, Flo
Reactivity:
Human
Format:
Unconjugated, Unmodified
Price
Catalog Number
$393
LS-C167337-400
Toll Free North America
206-374-1102
For Research Use Only

Overview

Antibody:
DDX49 Rabbit anti-Human Polyclonal (aa385-413) Antibody
Application:
IHC, IHC-P, WB, Flo
Reactivity:
Human
Format:
Unconjugated, Unmodified

Specifications

Description
DDX49 antibody LS-C167337 is an unconjugated rabbit polyclonal antibody to human DDX49 (aa385-413). Validated for Flow, IHC and WB.
Target
Human DDX49
Synonyms
DDX49 | DEAD box protein 49 | R27090_2
Host
Rabbit
Reactivity
Human (tested or 100% immunogen sequence identity)
Clonality
Polyclonal
Conjugations
Unconjugated
Purification
Protein A purified
Modifications
Unmodified
Epitope
aa385-413
Specificity
This DDX49 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 385-413 amino acids from the C-terminal region of human DDX49.
Applications
  • IHC
  • IHC - Paraffin (1:50 - 1:100)
  • Western blot (1:1000)
  • Flow Cytometry (1:10 - 1:50)
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
Presentation
PBS, 0.09% Sodium Azide
Storage
Maintain refrigerated at 2°C to 8°C for up to 6 months. For long term storage store at -20°C.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About DDX49
Q9Y6V7 NM_019070 NP_061943.2

Publications (0)

Customer Reviews (0)


Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 4/18/2024